Starpharma, SSL International to Produce Condoms With Microbicide VivaGel
October 17, 2007
Australian pharmaceutical company Starpharma and SSL International, which owns the Durex condom brand, have signed an agreement to develop condoms coated with Starpharma's microbicide VivaGel, the drug maker announced on Tuesday, the AAP/Age reports (AAP/Age, 10/16).
"We are delighted to be working with SSL, whom we believe will be an excellent co-development partner for VivaGel as a condom coating," Starpharma CEO Jackie Fairley said. She added, "Our development and commercialization activities for VivaGel are gathering momentum with this SSL agreement," which is the second condom-coating deal signed by Starpharma during the past three months (Starpharma release, 10/16).
WHO to Launch Campaign Aimed at Improving Nutrition Among HIV-Positive People in South, Southeast Asia
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.